Category: Friday Forensic
-
Watch me: I can sell you on CLS Holdings (CLSH.C), with its one dispensary, being a better buy than Trulieve (TRUL.C), with 52
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for the cannabis crowd, and a rough last year for everyone else. With Aurora Cannabis (ACB.T) losing the gross national product of Panama, Chuck Rifici bailing from…
-
Reuters journalist Pratima Desai sets up Giga Metals (GIGA.V) run and insider sell-off with fake story
UK-based commodities reporter Pratima Desai appears to have either been a useful idiot or a willing accomplice to a stock price run and subsequent insider sell-off of Canadian smallcap mining explorer Giga Metals (GIGA.V) after a false story based on unnamed sources suggesting the company was ‘in discussions’ to partnering with Tesla (TSLA.Q). LONDON (Reuters)…
-
Pump hard: ImagineAR (IP.C) is back to its old tricks, fueling a stock run on phantom deals and celebrity farts
I shot out of town for a few weeks recently, managing to get well drenched in a tent in the BC rainforest, and being without cellphone access for most of two weeks will teach a guy a thing or two about his relationship to the markets. It used to be said you should ‘sell in…
-
Hertz Donut: The robbery attempt going down at Hertz (HTZ.NYSE) has been approved by a judge
The Greater Fool Theory is the single greatest driving force of the markets right now. Balance sheets can eat a dick. Growth potential is irrelevant. Past performance and profits don’t even rate. All that matters is, “Yes, I’m trading like a moron, but there are ten other morons who’ll buy my mistakes for more money…
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
Flupocalypse 2020: Assuming you stay healthy, this is your ‘get rich’ moment
When the savings and loan crisis in the US hit in 1989, a lot of slow-moving investors lost their dough thinking the worst couldn’t possible happen. When the dotcom bubble burst in 2001, a lot of folks got torn up as stocks that had previously been 100-baggers went to zero. When the real estate market burned…
-
Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their…
-
![2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed]()
2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they…
-
Fire in the hole: Supreme Cannabis (FIRE.T) drops rough financials as expected, transition afoot
Ontario-based Supreme Cannabis (FIRE.T) released its Q2 2020 financials today and there were few surprises contained in its pages, bar perhaps the size of the quarterly loss. At a $17.3 million net loss after taxes (and a $10.4 million loss in adjusted EBITDA terms), FIRE shares fell in value below the $0.40 mark it’s been…
-
![MedMen (MMEN.C) CEO Adam Bierman resigns but his pockets continue to fill]()
MedMen (MMEN.C) CEO Adam Bierman resigns but his pockets continue to fill
From the day it landed on the stock market, MedMen (MMEN.C) was a company that drew derision and ire based almost entirely on the decision of its founders to lather themselves in hefty bonuses, hoard most of the voting shares, offer themselves enriching golden parachutes, and put themselves above the shareholders and the long term…
